Immunotherapy for neuroblastoma: turning promise into reality.

Gray, Juliet C. and Kohler, Janice A. (2009) Immunotherapy for neuroblastoma: turning promise into reality. Pediatric Blood and Cancer, 53, (6), pp. 931-940. (doi:10.1002/pbc.22153).


[img] PDF Gray_Kohler_2009.pdf - Version of Record
Restricted to Repository staff only

Download (228kB)


Neuroblastoma is one of the commonest and most aggressive paediatric malignancies. The majority of children present with metastatic disease for which long-term survival remains poor despite intensive multi-modal therapies. Toxicity from current treatment regimes is already significant, and there is little room to further intensify therapy. Alternative treatment strategies are therefore needed in order to improve survival. Immunotherapy is an attractive therapeutic option for these children as it potentially offers a much more specific and less toxic treatment than conventional therapies. This review discusses the different immunotherapy strategies that may be useful in neuroblastoma, their advantages and disadvantages and the challenges that need to be overcome to successfully use them clinically.

Item Type: Article
Digital Object Identifier (DOI): doi:10.1002/pbc.22153
ISSNs: 1545-5009 (print)
Related URLs:
Keywords: immunology, immunotherapy, neuroblastoma

ePrint ID: 73091
Date :
Date Event
November 2008Submitted
9 July 2009Published
Date Deposited: 01 Mar 2010
Last Modified: 18 Apr 2017 20:52
Further Information:Google Scholar

Actions (login required)

View Item View Item